By G HossainPosted on September 23, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs Novartis is the current radiopharma leader with two FDA-approved therapies in Pluvicto and Lutathera. Novartis bets up to $900M for radioligand therapy from China’s BoomRay Post navigation Pharmas face off for manufacturing talent amidst reshoring effortsNovo workforce down 13,000